Strickler, J. H., LoRusso, P., Yen, C.-J., Lin, C.-C., Kang, Y.-K., Kaminker, P., … Ramanathan, R. K. (2014). Phase 1, open-label, dose-escalation, and expansion study of ABT-700, an anti-C-met antibody, in patients (pts) with advanced solid tumors. In Journal of Clinical Oncology (Vol. 32, pp. 2507–2507). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2014.32.15_suppl.2507

Strickler, John H., Patricia LoRusso, Chia-Jui Yen, Chia-Chi Lin, Yoon-Koo Kang, Patrick Kaminker, Peter Ansell, et al. “Phase 1, open-label, dose-escalation, and expansion study of ABT-700, an anti-C-met antibody, in patients (pts) with advanced solid tumors.” In Journal of Clinical Oncology, 32:2507–2507. American Society of Clinical Oncology (ASCO), 2014. https://doi.org/10.1200/jco.2014.32.15_suppl.2507.

Strickler JH, LoRusso P, Yen C-J, Lin C-C, Kang Y-K, Kaminker P, et al. Phase 1, open-label, dose-escalation, and expansion study of ABT-700, an anti-C-met antibody, in patients (pts) with advanced solid tumors. In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2014. p. 2507–2507.

Strickler, John H., et al. “Phase 1, open-label, dose-escalation, and expansion study of ABT-700, an anti-C-met antibody, in patients (pts) with advanced solid tumors.” Journal of Clinical Oncology, vol. 32, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2014, pp. 2507–2507. Crossref, doi:10.1200/jco.2014.32.15_suppl.2507.

Strickler JH, LoRusso P, Yen C-J, Lin C-C, Kang Y-K, Kaminker P, Ansell P, Bhathena A, Wong S, Dudley MW, Naumovski L, Ramanathan RK. Phase 1, open-label, dose-escalation, and expansion study of ABT-700, an anti-C-met antibody, in patients (pts) with advanced solid tumors. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2014. p. 2507–2507.